An In-Silico Model of Lipoprotein Metabolism and Kinetics for the Evaluation of Targets and Biomarkers in the Reverse Cholesterol Transport Pathway
Figure 12
Simulation of ABCA1 up-regulation on a virtual population with low HDL-C (≤40 mg/dL).
Each virtual patient seleted for the treatment simulation had its ABCA1 activity () increased by 100% of its initial value.